Is technical support available after purchase?

Yes, we offer year-round online consultation in English and Chinese for cultivation and pest management.

Can I choose my own logistics provider?

Yes, clients can coordinate with their designated logistics agents or brokers for transportation.

Monstera Deliciosa Thai Constellation Variegated Tissue Culture Real Plants

Name: Monstera Deliciosa Thai Constellation Variegated Tissue Culture Real Plants
Brand: Foshan Sanshui Youngplants Co., Ltd.
SKU: 1989828885

Guangdong, ChinaFoshan Sanshui Youngplants Co., Ltd.

US$1.50-10.00

100 Pieces

Product profile

Customization

Available

Growth Environment

Subtropical

Watch Parts

Leaf

Model NO.

TC/72/90

Scent

Odorless

Application

Outdoor, Indoor

Transportation

by Air

Payment

T/T 100% 7days Before Shipping

Transport Package

Foam Box

Specification

TC/72TRAY

Trademark

YoungPlants

Origin

Foshan

HS Code

0602909199

Production Capacity

400000

Key features

Rare Variegated Cultivar: Monstera deliciosa 'Thai Constellation' with unique creamy white star-like leaf patterns.

Tissue Culture Origin: Developed through tissue culture in Thailand ensuring genetic stability and disease-free quality.

Global Supply Chain: Over 15 years experience serving 50+ countries with full logistics and customs support.

Fast Delivery Cycle: TC delivery in 25-30 days, Plugs in 15-20 days, 30% faster than industry average.

Comprehensive After-Sales: Replacement or refund within 15 working days for plant losses reported within 7 days.

ISO Quality Assurance: ISO-certified management with 100% pre-shipment inspection including pest and disease testing.

Custom Packaging: Specialized aseptic boxes for TC and humidity control trays for Plugs, optimized for climate.

Year-Round Technical Support: English and Chinese support for cultivation, pest control, and transplanting guidance.

Company profile

Foshan Sanshui Youngplants Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2008-08-31 CertifiedNearest Port: Foshan Port, Shenzhen PortAverage Response Time: ≤6.98hTerms of Payment: T/T

AI-Powered supplier vetting

SummaryFoshan Youngplants is a China-based limited company and factory specializing in tissue culture plants. It was established in 2008, began exporting in 2008, and reports that 71%–90% of sales come from exports. The supplier identifies 30,000 m² of manufacturing area, six in vitro laboratories covering more than 9,000 m², ten production lines, and 50 quality-control staff. It reports over 80 million annual output and serves markets including Japan, South Korea, Australia, and domestic customers. Evidence also indicates AEO, high-technology, nursery, and model laboratory honors, although certification details and validity are not provided. The supplier’s innovation, customization, after-sales, financial credibility, and customer-case strength cannot be fully verified from the supplied information.

Supplier typeThe supplier is identified as a limited company, factory, and combined business entity operating in Foshan, Guangdong, China. Its stated agricultural and biotechnology focus, together with tissue-culture production facilities, supports classification as a manufacturing supplier rather than only a trading intermediary.

CertificationsThe supplier states that it has received an Authorized Economic Operator (AEO) Certificate and honors including “One of The Best Nurseries,” “Model Tissue Culture Lab,” and “High Technology Expertise.” However, the slices do not provide certificate numbers, issuing dates, scope, or current validity.

R&D capabilityThe supplier specializes in in vitro tissue culture, operates six laboratories, reports more than 70 technologists and management personnel in one company description, and highlights innovation and new-cultivar cooperation. It also states that it has received high-technology recognition, providing positive evidence of technical capability, although R&D staffing information is inconsistent across slices and specific innovations are not documented.

Production capacityProduction evidence includes a stated annual output exceeding 80 million, a 30,000 m² manufacturing plant, six tissue-culture laboratories covering more than 9,000 m², ten production lines, and 50 quality-control staff. The supplier also reports one-month order fulfillment in both peak and off-peak seasons, indicating substantial stated capacity, although the output figure is presented in a company description without product-unit clarification.